Neurocrine Biosciences, Inc.
NBIX · NASDAQ
更新於 2026-10-13 14:04:20
$137.34-2.85%
- 今日最高
- $139.92
- 今日最低
- $136.63
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
...
K線圖趨勢，實際資料以交易頁為準
關鍵數據
- 昨天開盤價
- $142.37
- 昨天收盤價
- $141.37
- 成交量
- 1.09M
- 市值
- $14.37B
- 市盈率（P/E）
- 20.46X
- 每股收益（EPS）
- $6.82
昨天價格區間
$140.89$143.62
52週價格區間
$122.14$186.12
公司概況
- 板塊
- 醫療保健
- 行業
- 生物科技
- 子行業
- 藥品製造商 - 專科及仿製藥
- 總部
- 6027 EDGEWOOD BEND COURT, 聖地牙哥, 加州, 美國, 92130
- 國家
- 美國
- 上市日期
- 1996-05-23
- 財年截止
- 十二月
- 流通股數
- 100.55M
- CIK
- 0000914475
Neurocrine Biosciences, Inc. 是一間生物製藥公司，在美國從事神經、內分泌和精神疾病及障礙治療藥物的發現、開發和銷售。公司總部位於加州聖地牙哥。
財務指標
營業收入
2026-06-30
$959M
2026-03-31
$814.5M
2025-12-31
$805.5M
2025-09-30
$794.9M
營業支出
2026-06-30
$782.8M
2026-03-31
$614.7M
2025-12-31
$577M
2025-09-30
$541.9M
淨利潤
2026-06-30
$144.4M
2026-03-31
$197.9M
2025-12-31
$153.7M
2025-09-30
$209.5M
淨利潤率
2026-06-30
15.05%
2026-03-31
24.29%
2025-12-31
19.08%
2025-09-30
26.35%
每股收益
2026-06-30
$2.36
2026-03-31
$1.94
2025-12-31
$1.88
2025-09-30
$2.17
息稅折舊攤銷前利潤
2026-06-30
$189.9M
2026-03-31
$193.3M
2025-12-31
$235.4M
2025-09-30
$299.5M
有效稅率
2026-06-30
10.97%
2026-03-31
19.81%
2025-12-31
35.79%
2025-09-30
28.2%
| 項目 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| 營業收入 | $959M | $814.5M | $805.5M | $794.9M |
| 營業支出 | $782.8M | $614.7M | $577M | $541.9M |
| 淨利潤 | $144.4M | $197.9M | $153.7M | $209.5M |
| 淨利潤率 | 15.05% | 24.29% | 19.08% | 26.35% |
| 每股收益 | $2.36 | $1.94 | $1.88 | $2.17 |
| 息稅折舊攤銷前利潤 | $189.9M | $193.3M | $235.4M | $299.5M |
| 有效稅率 | 10.97% | 19.81% | 35.79% | 28.2% |
常見問題
風險提示
股價可能大幅波動，短時間內可能出現顯著漲跌。 數位資產與衍生性商品交易可能涉及槓桿、流動性等額外風險。 本頁內容僅供參考，不構成任何投資建議。 產品可用性與訪問可能因地區及適用法規而異。